Drug Type Small molecule drug |
Synonyms LOX-IN-3 |
Target |
Action inhibitors |
Mechanism Lysyl oxidase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (European Union) |
Molecular FormulaC13H13FN2O2S |
InChIKeyDHXXLGDTPFPYRH-WDZFZDKYSA-N |
CAS Registry2409963-83-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myelofibrosis | Preclinical | Sweden | 09 Dec 2025 | |
| Neoplasms | Discovery | - | - |





